proarrhythm respons channel blockad theoret model numer experi background use flecainid encainid cardiac arrhythmia suppress trial excess sudden cardiac death activ treatment group such event reentrant rhythm prematur stimul presenc anisotrop sodium channel avail drug channel function dispers refractori result drug-unbind process transit inexcit state excit state encainid flecainid unbind slowli second wherea lidocain moricizin unbind second method result comput represent cabl beeler-reut membran properti small msec vulner window msec last drive stimulu prematur vulner window unidirect block reentrant activ presenc unbind drug window addit msec durat msec delay antiarrhythm effect onset vulner window durat proarrhythm effect depend sodium channel avail recoveri process effect sodium channel avail membran depolar proarrhythm potenti durat vulner window hypothet use-depend class drug proarrhythm potenti non-use-depend drug conclus antiarrhythm proarrhythm properti pure sodium channel antagonist depend sodium channel avail price increas antiarrhythm efficaci suppress prematur ventricular contract increas proarrhythm vulner unsuppress prematur ventricular contract 